16.40
Schlusskurs vom Vortag:
$16.18
Offen:
$16.31
24-Stunden-Volumen:
389.86K
Relative Volume:
1.17
Marktkapitalisierung:
$303.32M
Einnahmen:
$62.81M
Nettoeinkommen (Verlust:
$-13.75M
KGV:
-20.50
EPS:
-0.8
Netto-Cashflow:
$153.00K
1W Leistung:
+30.89%
1M Leistung:
+29.13%
6M Leistung:
+193.38%
1J Leistung:
+96.64%
Optimizerx Corp Stock (OPRX) Company Profile
Firmenname
Optimizerx Corp
Sektor
Branche
Telefon
248-651-6558
Adresse
260 CHARLES STREET, WALTHAM, MI
Vergleichen Sie OPRX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OPRX
Optimizerx Corp
|
16.40 | 300.38M | 62.81M | -13.75M | 153.00K | -0.80 |
![]()
VEEV
Veeva Systems Inc
|
275.43 | 45.26B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
66.34 | 10.57B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
61.82 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
92.98 | 8.00B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
34.58 | 6.01B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
2024-01-03 | Eingeleitet | Barclays | Equal Weight |
2023-02-02 | Fortgesetzt | B. Riley Securities | Buy |
2022-11-01 | Eingeleitet | Stifel | Buy |
2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
2021-10-18 | Fortgesetzt | B. Riley Securities | Buy |
2021-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
2019-01-03 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
JMP Securities Forecasts Strong Price Appreciation for OptimizeRx (NASDAQ:OPRX) Stock - Defense World
OptimizeRx Corporation (NASDAQ:OPRX) Q2 2025 Earnings Call Transcript - Insider Monkey
JMP Securities Raises OptimizeRx (NASDAQ:OPRX) Price Target to $20.00 - MarketBeat
Is OptimizeRx Corporation stock bottoming outTechnical Trend Forecast for Investors - Newser
OptimizeRX price target raised to $20 from $14 at JMP on strong earnings - Investing.com Nigeria
Will breakout in OptimizeRx Corporation lead to full recoveryReal-Time Signal Tracking with Entry Level - Newser
What technical models suggest about OptimizeRx Corporation’s comebackDaily Stock Watch Summary with Key Insights - Newser
Can you recover from losses in OptimizeRx CorporationAI Short-Term Gain Forecast with Data - Newser
What makes OptimizeRx Corporation stock price move sharplySwing Trade Timing with Daily Forecast - Newser
Using AI based signals to follow OptimizeRx CorporationSteady Return Plan Based on Data Analysis - Newser
Trend analysis for OptimizeRx Corporation this weekFree Daily Growth Stock Pick Reports - Newser
Should you hold or exit OptimizeRx Corporation nowTechnical Screener for High Growth Stocks - Newser
Blair William & Co. IL Buys 29,648 Shares of OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat
Applying Elliott Wave Theory to OptimizeRx CorporationShort Term Gain Strategy with AI Logic - Newser
OptimizeRx Corp. (OPRX) Surpasses Q2 Earnings and Revenue Estimates - MSN
Stifel Nicolaus Forecasts Strong Price Appreciation for OptimizeRx (NASDAQ:OPRX) Stock - MarketBeat
Advanced analytics toolkit walkthrough for OptimizeRx CorporationTechnical Reversal Pattern Summary and Tracker - Newser
Healthcare Stocks Move in Friday's Pre-Market Session: OptimizeRx, Embecta, and More - AInvest
OptimizeRx Corp Surpasses Q2 2025 Estimates with 55% Revenue Increase, Achieves GAAP Net Income of $1.5M - AInvest
Stifel raises Optimizerx PT to $18, maintains Buy rating. - AInvest
Earnings call transcript: OptimizeRx Q2 2025 sees EPS surprise, stock jumps - Investing.com Nigeria
OptimizeRx Corp (OPRX) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
OptimizeRx Corp reports results for the quarter ended June 30Earnings Summary - TradingView
OptimizeRx Stock Rallies 22% After-Hours Thanks To Q2 Earnings Push - inkl
OPTIMIZERx earnings beat by $0.22, revenue topped estimates - Investing.com
OptimizeRx Q2 rev up 55% YoY to $29.2mln, raises FY25 guidance. - AInvest
OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance - The Manila Times
Press Release: OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance - 富途牛牛
Best Growth Stocks to Buy for August 7th - TradingView
Technical analysis overview for OptimizeRx Corporation stockTrend Reversal Watch with Entry Signals - Newser
Has OptimizeRx Corporation formed a bullish divergenceEntry Opportunity Screener with Confirmation - Newser
OptimizeRx Corp expected to post earnings of 2 cents a shareEarnings Preview - TradingView
Best Growth Stocks to Buy for August 5th - TradingView
OptimizeRx (OPRX) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Is OptimizeRx Corporation stock overvalued or undervaluedExceptional portfolio growth - Jammu Links News
Why is OptimizeRx Corporation stock attracting strong analyst attentionMaximize returns with strategic stock selection - Jammu Links News
How volatile is OptimizeRx Corporation stock compared to the marketMaximize returns with timely market signals - Jammu Links News
Should I hold or sell OptimizeRx Corporation stock in 2025Get real-time alerts on high-potential stocks - Jammu Links News
Best Growth Stocks to Buy for August 1st - Yahoo Finance
Published on: 2025-08-01 01:36:35 - Newser
Bull Of The Day: OptimizeRX (OPRX) - The Globe and Mail
Does OptimizeRx Have a Moat in the Crowded HealthTech Space? - Yahoo Finance
How did Optimizerx's revenue and expenses trend in Q4 2024? - AInvest
Finanzdaten der Optimizerx Corp-Aktie (OPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):